SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-----------------
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. )1
Immunicon Corporation
------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.001 par value
------------------------------------------------------------------------------
(Title of Class of Securities)
45260A 10 7
------------------------------------------------------------------------------
(CUSIP Number)
April 14, 2004
-----------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[X] Rule 13d-1(d)
--------
1 The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page. The information required on
the remainder of this cover page shall not be deemed to be "filed" for the
purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise
subject to the liabilities of that section of the Act but shall be subject to
all other provisions of the Act.
CUSIP No. 45260A 10 7 Page 2 of 6 Pages
--------------------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Johnson & Johnson
22-1024240
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
New Jersey
--------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY
EACH --------------------------------------------
REPORTING 6. SHARED VOTING POWER
PERSON
WITH 1,771,571 shares of Common Stock
--------------------------------------------
7. SOLE DISPOSITIVE POWER
-0-
--------------------------------------------
8. SHARED DISPOSITIVE POWER
1,771,571 shares of Common Stock
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,771,571 shares of Common Stock
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[ ]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
7.67%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON
CO
--------------------------------------------------------------------------------
CUSIP No. 45260A 10 7 Page 3 of 6 Pages
--------------------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Johnson & Johnson
22-2007137
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
New Jersey
--------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY
EACH --------------------------------------------
REPORTING 6. SHARED VOTING POWER
PERSON
WITH 1,771,571 shares of Common Stock
--------------------------------------------
7. SOLE DISPOSITIVE POWER
-0-
--------------------------------------------
8. SHARED DISPOSITIVE POWER
1,771,571 shares of Common Stock
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,771,571 shares of Common Stock
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[ ]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
7.67%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON
CO
--------------------------------------------------------------------------------
CUSIP No. 45260A 10 7 Page 4 of 6 Pages
SCHEDULE 13G
ITEM 1(a) - NAME OF ISSUER:
Immunicon Corporation
ITEM 1(b) - ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
3401 Masons Mill Road
Suite 100
Huntington Valley, PA 19006
ITEM 2(a) - NAME OF PERSON FILING:
This statement is being filed by Johnson & Johnson, a New Jersey
corporation ("J&J"), and Johnson & Johnson Development Corporation, a New Jersey
corporation ("JJDC"). JJDC is a wholly-owned subsidiary of J&J. The securities
reported herein as being held by J&J and JJDC are directly beneficially owned by
JJDC. J&J may be deemed to indirectly beneficially own the securities that are
directly beneficially owned by JJDC.
ITEM 2(b) - ADDRESS OF PRINCIPAL BUSINESS OFFICE:
One Johnson & Johnson Plaza
New Brunswick, NJ 08933
ITEM 2(c) - CITIZENSHIP:
J&J: New Jersey
JJDC: New Jersey
ITEM 2(d) - TITLE OF CLASS OF SECURITIES:
Common Stock, $.001 par value per share ("Common
Stock")
ITEM 2(e) - CUSIP NUMBER:
45260A 10 7
ITEM 3 - STATEMENTS FILED PURSUANT TO RULES 13D-1(B) OR
13D-2(B) OR (C):
Not applicable.
ITEM 4 - OWNERSHIP:
(a) Amount Beneficially Owned:
J&J: 1,771,571 shares of Common Stock
JJDC: 1,771,571 shares of Common Stock
(b) Percent of Class:
J&J: 7.67%
JJDC: 7.67%
CUSIP No. 45260A 10 7 Page 5 of 6 Pages
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: -0-
(ii) shared power to vote or to direct the vote:
J&J: 1,771,571 shares of Common Stock
JJDC: 1,771,571 shares of Common Stock
(iii) sole power to dispose or to direct the
disposition of: -0-
(iv) shared power to dispose or to direct the
disposition of:
J&J: 1,771,571 shares of Common Stock
JJDC: 1,771,571 shares of Common Stock
ITEM 5 - OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
Not applicable.
ITEM 6 - OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER
PERSON:
Not applicable.
ITEM 7 - IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH
ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT COMPANY:
Not applicable.
ITEM 8 - IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:
Not applicable.
ITEM 9 - NOTICE OF DISSOLUTION OF GROUP:
Not applicable.
ITEM 10 - CERTIFICATION:
Not applicable.
CUSIP No. 45260A 10 7 Page 5 of 6 Pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
JOHNSON & JOHNSON
By /s/ MICHAEL H. ULLMANN
------------------------------
Name: Michael H. Ullmann
Title: Secretary
JOHNSON & JOHNSON DEVELOPMENT
CORPORATION
By /s/ MANISH YADAV
------------------------------
Name: Manish Yadav
Title: Secretary
Dated: February 1, 2005